REFERENCES
1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.
2. Cervantes A, Adam R, Roselló S, et al.; ESMO Guidelines Committee. Electronic address: [email protected]. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:10-32.
3. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233-54.
4. Creasy JM, Sadot E, Koerkamp BG, et al. Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? Surgery. 2018;163:1238-44.
5. Ratti F, Cipriani F, Fiorentini G, et al. Evolution of surgical treatment of colorectal liver metastases in the real world: single center experience in 1212 cases. Cancers. 2021:13.
6. Bond MJG, Bolhuis K, Loosveld OJL, et al.; Dutch Colorectal Cancer Group. First-line systemic treatment for initially unresectable colorectal liver metastases: post hoc analysis of the CAIRO5 randomized clinical trial. JAMA Oncol. 2025;11:36-45.
7. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-57; discussion 657.
8. Allard MA, Adam R, Giuliante F, et al. Long-term outcomes of patients with 10 or more colorectal liver metastases. Br J Cancer. 2017;117:604-11.
9. Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265:958-68.
10. Karagkounis G, McIntyre SM, Wang T, et al. Rates and patterns of recurrence after microwave ablation of colorectal liver metastases: a per lesion analysis of 416 tumors in the era of 2.45 GHz generators. Ann Surg Oncol. 2023;30:6571-8.
11. Imai K, Allard MA, Castro Benitez C, et al. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. Br J Surg. 2017;104:570-9.
12. Liu M, Wang K, Wang Y, et al. Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis. HPB. 2021;23:1586-94.
13. Liu M, Wang Y, Wang K, et al. Combined ablation and resection (CARe) for resectable colorectal cancer liver metastases - a propensity score matching study. Eur J Surg Oncol. 2023;49:106931.
14. Elfrink AKE, Nieuwenhuizen S, van den Tol MP, et al.; Dutch Hepato Biliary Audit Group. Hospital variation in combined liver resection and thermal ablation for colorectal liver metastases and impact on short-term postoperative outcomes: a nationwide population-based study. HPB. 2021;23:827-39.
15. Xourafas D, Pawlik TM, Ejaz A, et al. Impact of concomitant ablation on the perioperative outcomes of patients with colorectal liver metastases undergoing hepatectomy: a propensity score matched nationwide analysis. HPB. 2019;21:1079-86.
16. Graaff MR, Klaase JM, den Dulk M, et al; Dutch Hepato Biliary Audit Group, Collaborators. Trends and overall survival after combined liver resection and thermal ablation of colorectal liver metastases: a nationwide population-based propensity score-matched study. HPB. 2024;26:34-43.
17. Karanicolas PJ, Jarnagin WR, Gonen M, et al. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 2013;148:597-601.
18. Dai Y, Zhang Y, He W, et al. Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone. Int J Hyperthermia. 2021;38:372-81.
19. Amygdalos I, Hitpass L, Schmidt F, et al. Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastases. Langenbecks Arch Surg. 2023;408:343.
20. Sawa Y, Kawaguchi Y, Miyata A, et al. Gradual expansion of the indications for minimally invasive liver resection to include highly complex procedures may improve postoperative outcomes. Mini-invasive Surg. 2024;8:30.
21. Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, et al. Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg. 2018;267:199-207.
22. Aghayan DL, Kazaryan AM, Dagenborg VJ, et al.; OSLO-COMET Survival Study Collaborators. Long-term oncologic outcomes after laparoscopic versus open resection for colorectal liver metastases: a randomized trial. Ann Intern Med. 2021;174:175-82.
23. Robles-Campos R, Lopez-Lopez V, Brusadin R, et al. Open versus minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): a prospective randomized controlled trial. Surg Endosc. 2019;33:3926-36.
24. Fichtinger RS, Aldrighetti LA, Abu Hilal M, et al.; ORANGE II PLUS Collaborative. Laparoscopic versus open hemihepatectomy: the ORANGE II PLUS multicenter randomized controlled trial. J Clin Oncol. 2024;42:1799-809.
25. Zhang D, Chen Z, Zhang L, et al. Application of laparoscopic hepatectomy combined with intraoperative microwave ablation in colorectal cancer liver metastasis. J Vis Exp. 2023.
26. Vandeputte M, Saveyn T, Lutin B, De Meyere C, Parmentier I, D’Hondt M. Combined ablation and resection for colorectal liver metastases in the minimally invasive surgical era. Surg Laparosc Endosc Percutan Tech. 2023;33:121-8.
27. Song H, Li Z, Zhang S, et al. Laparoscopic resection combined with ablation for multiple colorectal liver metastases: a multicentre propensity-matched analysis. Surg Endosc. 2025;39:6514-24.
28. Sasaki K, Margonis GA, Andreatos N, et al. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes. J Surg Res. 2016;206:182-9.
29. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
30. Siriwardena AK, Serrablo A, Fretland ÅA, et al. Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE. Br J Surg. 2023;110:1161-70.
31. Boyev A, Tzeng CD, Maki H, et al. Local therapy improves survival for early recurrence after resection of colorectal liver metastases. Ann Surg Oncol. 2024;31:2547-56.
32. van der Lei S, Puijk RS, Dijkstra M, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol. 2025;26:187-99.
33. Serenari M, Ratti F, Stocco A, et al. Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases. Surg Endosc. 2024;38:2611-21.
34. Görgec B, Benedetti Cacciaguerra A, Pawlik TM, et al. An international expert Delphi consensus on defining Textbook Outcome in Liver Surgery (TOLS). Ann Surg. 2023;277:821-8.
35. Halls MC, Berardi G, Cipriani F, et al. Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection. Br J Surg. 2018;105:1182-91.
36. Takeda Y, Mise Y, Ito H, et al. Repeat resection for advanced colorectal liver metastases-does it have the potential for cure? World J Surg. 2022;46:2253-61.
37. Dupré A, Jones RP, Diaz-Nieto R, Fenwick SW, Poston GJ, Malik HZ. Curative-intent treatment of recurrent colorectal liver metastases: a comparison between ablation and resection. Eur J Surg Oncol. 2017;43:1901-7.
